Social News
Written by: Golden Chess
2021-03-19 22:19
Last update date: 2021-03-19 22:19
The new crown vaccination plan in Hong Kong was launched at the end of last month. Experts recently pointed out that the BioNTech vaccine currently used in Hong Kong has a protection rate of 85% to over 90% against variant virus strains in the United Kingdom and Brazil, but against the variant virus in South Africa. Nothing works."
As for the Coxing vaccine, there is still no data to prove whether it is effective against the mutant virus.
The "Global Times" reported that a third dose of vaccine was started in the Mainland and its effect was monitored.
The Sinopharm Group and Kexing used in Hong Kong are both studying whether the third dose of the vaccine can increase the level of antibodies, the overall effectiveness of the new coronavirus, and the effectiveness of the mutant virus.
▼See the details of the scheduled vaccination and side effects of Kexing and BioNTech in the 3 pictures▼
At present, Kexing vaccine needs to be vaccinated in Hong Kong with 2 doses, each with an interval of 28 days.
"Global Times" reported that the current data do not show that the variant virus strain has a major impact on the effectiveness of vaccines in the Mainland, but the mainland vaccine manufacturer is conducting follow-up experiments against the variant virus strain, including the start of the third dose and monitoring it. effect.
Members of the Mainland Vaccine R&D Expert Group: No significant reduction in vaccine activity
The report also stated that the Kexing vaccine being used in Hong Kong is undergoing laboratory research to follow up how the new coronavirus has mutated and to study possible treatments.
Yin Weidong, chairman of Kexing Holdings, told the Global Times that the company is conducting experiments to study whether the third dose of booster will affect the level of protection.
The members of the mainland vaccine research and development expert group told the Global Times that the mainland vaccine manufacturers have collected data and evaluated the vaccine's effectiveness against the variant virus strains, and found that the vaccine activity has not been significantly reduced, including the variant virus strains in South Africa.
▼2.22 Chief Executive Carrie Lam Cheng Yuet-ngor led the Secretary to vaccinate Kexing vaccine▼
+14
+14
+14
▼2.26 The first day of Kexing vaccination in the Central Library Exhibition Hall▼
+14
+14
+14
Kexing Vaccine (Photo by Luo Guohui/Data Picture)
Fubitai Vaccine | The 66-year-old diabetic man fainted in the car and the rescue failed 3 days before the vaccination
New Crown Vaccine|Want to change after a dose?
Doctor warns or increases the risk of side effects
Hong Kong recorded 96 cases of variant viruses, experts explain the low effectiveness of Forbita AstraZeneca vaccine against South African variants
Kexing Vaccine|Private doctors reiterated the old news about bribery and suggested that "not hit" provokes criticism and the form has been removed
New Crown Vaccine | Some residential homes with only one growth are willing to get an injection. The Elderly Association is not optimistic about the relaxation of visits
Vaccination Expansion Group International Students Inject IT Men Going to Britain to Choose Fubitai: Higher Protection Rate
01News
New crown pneumonia new crown vaccine vaccination China Kexing BioNTech/Fosun vaccine